Literature DB >> 15745203

Drug misuse: a review of treatments.

Clare Gerada1.   

Abstract

Treating drug users is something that every health professional should be able to do, whether providing brief interventions or harm minimisation advice or providing an assessment and directing the user for further care. Unfortunately, despite a growing problem, few health professionals outside specialist addiction services have the skills, experience and knowledge to provide patients with effective pharmacological interventions. Many of the pharmacological treatment options, such as methadone maintenance, have had extensive research and have been shown to be effective in a number of outcome areas. Newer treatments, such as buprenorphine- and naltrexone-assisted detoxification have a growing research base. This article provides a brief overview of treatments options and the impact of drug use on social and medical care services.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15745203      PMCID: PMC4954073          DOI: 10.7861/clinmedicine.5-1-69

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN: 1470-2118            Impact factor:   2.659


  3 in total

1.  Elevated platelet vesicular monoamine transporter 2 in former heroin addicts maintained on methadone.

Authors:  K Schwartz; I Herman; G Peer; A Weizman; M Rehavi
Journal:  J Neural Transm (Vienna)       Date:  2006-07-20       Impact factor: 3.575

2.  Randomized trial comparing two treatment strategies using prize-based reinforcement of abstinence in cocaine and opiate users.

Authors:  Kenzie L Preston; Udi E Ghitza; John P Schmittner; Jennifer R Schroeder; David H Epstein
Journal:  J Appl Behav Anal       Date:  2008

3.  General practice patients treated for substance use problems: a cross-national observational study in Belgium.

Authors:  Nicole Boffin; Jerome Antoine; Sarah Moreels; Simeon Wanyama; Karin De Ridder; Lieve Peremans; Marc Vanmeerbeek; Viviane Van Casteren
Journal:  BMC Public Health       Date:  2016-12-08       Impact factor: 3.295

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.